Product Reports Resources Pricing Login Book a demo

BionicM

Health Tech & Medtech · Tokyo, Japan · Founded 2018

Robotic-powered prosthetic knees for lower-limb amputees MoreLess

BionicM Inc. is a developer of powered prosthetic solutions for lower-limb amputees, founded in 2018 as a spin-off from the University of Tokyo. The company's creation stems from the doctoral research of its founder and CEO, Dr. Sun Xiaojun, who is himself an amputee. Sun lost his right leg to bone cancer at age nine and used crutches for 15 years before getting his first prosthesis, an experience that drove him to develop better solutions. After earning a master's degree and working as an engineer at Sony, he pursued a Ph.D. at the University of Tokyo, focusing on robotic prosthetic legs, which led to the founding of BionicM.

The company's main business is the research, development, and commercialization of robotic prostheses. Its flagship product, the Bio Leg®, is a powered prosthetic knee that utilizes robotics and AI to replicate lost muscle strength, assisting with movements like walking and ascending stairs. This technology is designed to reduce the physical burden on users, enabling more natural and intuitive movement. The Bio Leg®, which weighs about six pounds and has a full-day battery life, has received FDA Class II registration and U.S. medical insurance coverage. The company is also developing a more affordable model, the Cybo Leg, and exploring features to collect biometric data to help clinicians guide gait training.

BionicM operates on a business model that involves partnering with third-party socket manufacturers, which helps make its products more affordable than some competing devices. The company launched sales in China and Japan in 2021 and entered the U.S. market, the world's largest for prosthetics, in August 2024. To support its global expansion, BionicM established a U.S. subsidiary in Virginia and has raised approximately $12.7 million in total funding from investors including UTEC, JST, and Shinsei Corporate Investment.

Keywords: powered prosthetics, robotic knee, lower-limb amputees, Bio Leg, assistive technology, mobility solutions, medical devices, humanoid robotics, biomechatronics, prosthetic leg, microprocessor knee, gait assistance, rehabilitation technology, amputation, University of Tokyo spin-off, artificial intelligence, biomechanics, wearable robotics, healthcare robotics, medtech

Talent graph

BionicM's talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on BionicM's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
Hong Kong Science & Technology Parks Corporation
Series A 9 investors entered at this stage
UTEC - The University of Tokyo Edge Capital Partners
UTokyo Innovation Platform
Japan Science and Technology Agency
Shinsei Corporate Investment
Kiraboshi Capital
AIS Capital
NVenture Capital
Chibagin Capital
Yoshitsune Ido

Global footprint

Where BionicM has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States54.5%
🇯🇵 Japan45.5%
2 countries shown

Market sentiment

What the market is saying about BionicM

An AI-synthesized read of the highest-engagement posts about BionicM on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BionicM on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.